FOVENTA THERAPEUTICS LIMITEDActive

Company number 08803638Private limited companyIncorporated 2013
⚠ Accounts overdue. The next accounts were due on 30 Sep 2026 and had not been filed when the register was last updated.

Key figures

−£6,844,111-22.0%
Net assets 2025
-7.5 m-5 m-2.5 m02.5 m202020212022202320242025

FOVENTA THERAPEUTICS LIMITED does not disclose its turnover in its latest accounts; the profit for the year is as stated in the accounts.

Ratios

2025
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
05 m10 m202020212022202320242025
Filed accounts2020–2025
20212022202320242025
Profit for the year-2,844,13636,989-2,555,638-1,631,424-1,236,357
Cash at bank and in hand3,601,1013,922,3852,009,4531,108,416475,734
Total assets5,125,4705,477,4182,529,1051,221,319622,868
Total liabilities6,623,8276,937,4836,522,4106,832,0597,467,246
Net assets / total equity-1,406,175-1,430,786-3,983,841-5,609,374-6,844,111
Average number of employees17151400

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: FOVENTA THERAPEUTICS LIMITED

Company

FOVENTA THERAPEUTICS LIMITED is a private limited company registered with Companies House under company number 08803638. It was incorporated on 5 Dec 2013. Its status is active. The registered office is in Cambridge (CB22). Its nature of business (SIC 2007) is manufacture of basic pharmaceutical products (21100).

Accounts

The latest accounts in the database are for 2025 (period ending 31 Dec 2025); the company files full accounts. Loss for the year was £1,236,357. Net assets were −£6,844,111, down 22% on the previous year. Cash at bank and in hand was £475,734. Total assets were £622,868 and total liabilities £7,467,246. The company had an average of 0 employees. Figures are available for 6 financial years (2020–2025).

Filing deadlines

The next accounts are due by 30 Sep 2026. The next confirmation statement is due by 19 Dec 2026.